1. Home
  2. CRWD vs MRK Comparison

CRWD vs MRK Comparison

Compare CRWD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CrowdStrike Holdings Inc.

CRWD

CrowdStrike Holdings Inc.

HOLD

Current Price

$701.68

Market Cap

174.3B

Sector

Technology

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$128.34

Market Cap

281.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWD
MRK
Founded
2011
2000
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.3B
281.2B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
CRWD
MRK
Price
$701.68
$128.34
Analyst Decision
Buy
Buy
Analyst Count
48
17
Target Price
$507.00
$125.59
AVG Volume (30 Days)
3.2M
8.6M
Earning Date
06-02-2026
04-30-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
8.01
EPS
0.11
N/A
Revenue
$4,812,005,000.00
$65,011,000,000.00
Revenue This Year
$24.85
$3.61
Revenue Next Year
$21.40
$5.41
P/E Ratio
$6,165.82
N/A
Revenue Growth
21.71
1.31
52 Week Low
$342.72
$76.66
52 Week High
$785.66
$125.96

Technical Indicators

Market Signals
Indicator
CRWD
MRK
Relative Strength Index (RSI) 59.70 70.38
Support Level $463.35 $112.68
Resistance Level $785.66 N/A
Average True Range (ATR) 31.68 3.07
MACD -7.46 0.91
Stochastic Oscillator 81.82 97.44

Price Performance

Historical Comparison
CRWD
MRK

About CRWD CrowdStrike Holdings Inc.

CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: